These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2878715)

  • 1. High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome.
    Butler MG; Repaske DR; Joseph GM; Phillips JA
    Cancer Genet Cytogenet; 1987 Jan; 24(1):129-35. PubMed ID: 2878715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage analysis of a DNA marker localized to 20p12 and multiple endocrine neoplasia type 2A.
    Goodfellow PJ; White BN; Holden JJ; Duncan AM; Sears EV; Wang HS; Berlin L; Kidd KK; Simpson NE
    Am J Hum Genet; 1985 Sep; 37(5):890-7. PubMed ID: 2864854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies.
    Babu VR; Van Dyke DL; Flejter WL; Jackson CE
    Am J Med Genet; 1987 Jul; 27(3):739-48. PubMed ID: 2888311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic studies of individuals from four kindreds with multiple endocrine neoplasia type II syndrome.
    Butler MG; Rames LJ; Joseph GM
    Cancer Genet Cytogenet; 1987 Oct; 28(2):253-60. PubMed ID: 2887277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
    Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
    N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 2 (Sipple's syndrome): clinical and cytogenetic analysis of a kindred.
    Zatterale A; Stabile M; Nunziata V; Di Giovanni G; Vecchione R; Ventruto V
    J Med Genet; 1984 Apr; 21(2):108-11. PubMed ID: 6143828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage analysis of multiple endocrine neoplasia type 2A (MEN-2A) and three DNA markers on chromosome 20: evidence against synteny.
    Farrer LA; Goodfellow PJ; White BN; Holden JJ; Kidd JR; Simpson NE; Kidd KK
    Cancer Genet Cytogenet; 1987 Aug; 27(2):327-34. PubMed ID: 2885081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
    Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
    Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.
    Babu VR; Van Dyke DL; Jackson CE
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2525-8. PubMed ID: 6585814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of MEN 203 as a polymorphic DNA probe in screening multiple endocrine neoplasia 2a.
    Kojima K; Totsuka Y
    Endocrinol Jpn; 1991 Dec; 38(6):583-7. PubMed ID: 1688047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved predictive test for MEN2, using flanking dinucleotide repeats and RFLPs.
    Howe JR; Lairmore TC; Mishra SK; Dou S; Veile R; Wells SA; Donis-Keller H
    Am J Hum Genet; 1992 Dec; 51(6):1430-42. PubMed ID: 1361102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
    Yang KP; Nguyen CV; Castillo SG; Samaan NA
    Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sipple's syndrome. Review of the literature and personal case load].
    Lamberto M; Novi RF; Porta M; Limone P
    Minerva Endocrinol; 1989; 14(4):199-205. PubMed ID: 2576884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2.
    Schuffenecker I; Narod SA; Ezekowitz RA; Sobol H; Feunteun J; Lenoir GM
    Cytogenet Cell Genet; 1991; 56(2):99-102. PubMed ID: 1672848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage and chromosome study of multiple endocrine neoplasia IIa.
    Emmertsen K; Lamm LU; Rasmussen KZ; Elbrønd O; Hansen HH; Henningsen K; Jørgensen J; Petersen GB
    Cancer Genet Cytogenet; 1983 Jul; 9(3):251-9. PubMed ID: 6134579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S; Sato T; Takiguchi-Shirahama S; Nakamura Y
    Endocr J; 1995 Aug; 42(4):527-36. PubMed ID: 8556060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta subunit locus of the human fibronectin receptor: DNA restriction fragment length polymorphism and linkage mapping studies.
    Wu JS; Giuffra LA; Goodfellow PJ; Myers S; Carson NL; Anderson L; Hoyle LS; Simpson NE; Kidd KK
    Hum Genet; 1989 Nov; 83(4):383-90. PubMed ID: 2572537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where is the locus for multiple endocrine neoplasia type 2A?
    Simpson NE; Kidd KK
    Henry Ford Hosp Med J; 1987; 35(2-3):168-71. PubMed ID: 2891652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.